SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Suven Life Sciences - Quaterly Results

04 Nov 2023 Evaluate
The sales slipped to Rs. 30.60 millions, down -30.23% for the September 2023 quarter as against Rs. 43.86 millions during the year-ago period.The Total Profit for the quarter ended September 2023 of Rs. 27.55 millions grew from Rs.-89.33 millions Operating profit Margin for the quarter ended September 2023 improved to -29.34% as compared to -72.44% of corresponding quarter ended September 2022


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 30.60 43.86 -30.23 68.57 79.25 -13.48 135.39 118.44 14.31
Other Income 51.42 2.06 2396.12 107.82 6.42 1579.44 84.49 16.01 427.73
PBIDT -29.34 -72.44 -59.50 -40.89 -138.74 -70.53 -192.95 -350.41 -44.94
Interest 0.42 0.69 -39.13 0.93 1.71 -45.61 2.89 5.30 -45.47
PBDT 44.81 -73.13 -161.27 32.75 -80.45 -140.71 -135.84 -318.55 -57.36
Depreciation 17.26 16.20 6.54 33.91 32.01 5.94 65.43 43.93 48.94
PBT 27.55 -89.33 -130.84 -1.16 -112.46 -98.97 -201.27 -362.48 -44.47
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 27.55 -89.33 -130.84 -1.16 -112.46 -98.97 -201.27 -362.48 -44.47
Equity 218.07 145.38 50.00 218.07 145.38 50.00 218.07 145.38 50.00
PBIDTM(%) -95.88 -165.16 -41.95 -59.63 -175.07 -65.94 -142.51 -295.85 -51.83

Suven Life Sciences Share Price

195.90 -0.10 (-0.05%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×